EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation

Yanmin Zhao, Jimin Shi, Yi Luo, Fei Gao, Yamin Tan, Xiaoyu Lai, Jian Yu, Guoqing Wei, He Huang

Biology of Blood and Marrow Transplantation · 2020-05 · 26 (5) · e128-e133

DOI: 10.1016/j.bbmt.2020.01.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-05. Verfasst von Yanmin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology,…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationCalcineurin InhibitorsHerpesvirus 4, HumanHumansNitrilesPyrazolesPyrimidinesTransplantation Conditioning

Stichwörter der Autor:innen

Allogeneic stem cell transplantationCalcineurin inhibitorGraft-versus-host diseaseRuxolitinib

Substanzen

Calcineurin InhibitorsNitrilesPyrazolesPyrimidinesruxolitinib

Autor:innen und Institutionen

  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: w…
  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: h…

Förderung

  • NCI NIH HHS
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Y., Shi, J., Luo, Y., Gao, F., Tan, Y., Lai, X., Yu, J., Wei, G., & Huang, H. (2020). Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 26(5), e128-e133. https://doi.org/10.1016/j.bbmt.2020.01.012

Vancouver

Zhao Y, Shi J, Luo Y, Gao F, Tan Y, Lai X, et al. Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2020;26(5):e128-e133. doi:10.1016/j.bbmt.2020.01.012

BibTeX
@article{Zhao2020,
  author = {Zhao, Yanmin and Shi, Jimin and Luo, Yi and Gao, Fei and Tan, Yamin and Lai, Xiaoyu and Yu, Jian and Wei, Guoqing and Huang, He},
  title = {Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {5},
  pages = {e128--e133},
  doi = {10.1016/j.bbmt.2020.01.012}
}
Kostenlos starten →